| Symbol |
Name |
|
A2M
|
alpha-2-macroglobulin
|
|
ABCA2
|
ATP-binding cassette, sub-family A (ABC1), member 2
|
|
ABCB1
|
ATP-binding cassette, sub-family B (MDR/TAP), member 1
|
|
ABCC1
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 1
|
|
ABCC10
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 10
|
|
ABCC4
|
ATP-binding cassette, sub-family C (CFTR/MRP), member 4
|
|
ABCG2
|
ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group)
|
|
ABI1
|
abl-interactor 1
|
|
ABL1
|
ABL proto-oncogene 1, non-receptor tyrosine kinase
|
|
ACADS
|
acyl-CoA dehydrogenase, C-2 to C-3 short chain
|
|
ACE
|
angiotensin I converting enzyme
|
|
ACE2
|
angiotensin I converting enzyme 2
|
|
ACHE
|
acetylcholinesterase (Yt blood group)
|
|
ACKR3
|
atypical chemokine receptor 3
|
|
ACP1
|
acid phosphatase 1, soluble
|
|
ACSM1
|
acyl-CoA synthetase medium-chain family member 1
|
|
ACTA2
|
actin, alpha 2, smooth muscle, aorta
|
|
ACTN3
|
actinin, alpha 3 (gene/pseudogene)
|
|
ADA
|
adenosine deaminase
|
|
ADAM12
|
ADAM metallopeptidase domain 12
|
|
ADAM17
|
ADAM metallopeptidase domain 17
|
|
ADAMTS13
|
ADAM metallopeptidase with thrombospondin type 1 motif, 13
|
|
ADAR
|
adenosine deaminase, RNA-specific
|
|
ADCYAP1
|
adenylate cyclase activating polypeptide 1 (pituitary)
|
|
ADCYAP1R1
|
adenylate cyclase activating polypeptide 1 (pituitary) receptor type I
|
|
ADD1
|
adducin 1 (alpha)
|
|
ADGRG1
|
adhesion G protein-coupled receptor G1
|
|
ADH1B
|
alcohol dehydrogenase 1B (class I), beta polypeptide
|
|
ADH1C
|
alcohol dehydrogenase 1C (class I), gamma polypeptide
|
|
ADIPOQ
|
adiponectin, C1Q and collagen domain containing
|
|
ADM
|
adrenomedullin
|
|
ADRA2A
|
adrenoceptor alpha 2A
|
|
ADRA2B
|
adrenoceptor alpha 2B
|
|
ADRB1
|
adrenoceptor beta 1
|
|
ADRB2
|
adrenoceptor beta 2, surface
|
|
ADRB3
|
adrenoceptor beta 3
|
|
ADRBK1
|
adrenergic, beta, receptor kinase 1
|
|
AFP
|
alpha-fetoprotein
|
|
AGR2
|
anterior gradient 2
|
|
AGT
|
angiotensinogen (serpin peptidase inhibitor, clade A, member 8)
|
|
AGTR1
|
angiotensin II receptor, type 1
|
|
AGTR2
|
angiotensin II receptor, type 2
|
|
AHR
|
aryl hydrocarbon receptor
|
|
AIRE
|
autoimmune regulator
|
|
AKR1B10
|
aldo-keto reductase family 1, member B10 (aldose reductase)
|
|
AKR1C1
|
aldo-keto reductase family 1, member C1
|
|
AKR1C2
|
aldo-keto reductase family 1, member C2
|
|
AKT1
|
v-akt murine thymoma viral oncogene homolog 1
|
|
ALDH1A1
|
aldehyde dehydrogenase 1 family, member A1
|
|
ALDH2
|
aldehyde dehydrogenase 2 family (mitochondrial)
|
|
ALKBH2
|
alkB, alkylation repair homolog 2 (E. coli)
|
|
AMACR
|
alpha-methylacyl-CoA racemase
|
|
AMH
|
anti-Mullerian hormone
|
|
ANGPT1
|
angiopoietin 1
|
|
ANGPT2
|
angiopoietin 2
|
|
ANKRD11
|
ankyrin repeat domain 11
|
|
ANO1
|
anoctamin 1, calcium activated chloride channel
|
|
ANPEP
|
alanyl (membrane) aminopeptidase
|
|
AOC3
|
amine oxidase, copper containing 3
|
|
APC
|
adenomatous polyposis coli
|
|
APEX1
|
APEX nuclease (multifunctional DNA repair enzyme) 1
|
|
APOA1
|
apolipoprotein A-I
|
|
APOA5
|
apolipoprotein A-V
|
|
APOB
|
apolipoprotein B
|
|
APOBEC3H
|
apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H
|
|
APOC3
|
apolipoprotein C-III
|
|
APOE
|
apolipoprotein E
|
|
APP
|
amyloid beta (A4) precursor protein
|
|
APPL1
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1
|
|
APPL2
|
adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 2
|
|
AR
|
androgen receptor
|
|
AREG
|
amphiregulin
|
|
ARMS2
|
age-related maculopathy susceptibility 2
|
|
ARRB2
|
arrestin, beta 2
|
|
ART3
|
ADP-ribosyltransferase 3
|
|
ASAH1
|
N-acylsphingosine amidohydrolase (acid ceramidase) 1
|
|
ASXL1
|
additional sex combs like transcriptional regulator 1
|
|
ATM
|
ATM serine/threonine kinase
|
|
ATOH1
|
atonal homolog 1 (Drosophila)
|
|
ATOH7
|
atonal homolog 7 (Drosophila)
|
|
ATP2A1
|
ATPase, Ca++ transporting, cardiac muscle, fast twitch 1
|
|
ATP2A2
|
ATPase, Ca++ transporting, cardiac muscle, slow twitch 2
|
|
ATP2B4
|
ATPase, Ca++ transporting, plasma membrane 4
|
|
ATP7B
|
ATPase, Cu++ transporting, beta polypeptide
|
|
ATR
|
ATR serine/threonine kinase
|
|
AURKA
|
aurora kinase A
|
|
AURKB
|
aurora kinase B
|
|
B2M
|
beta-2-microglobulin
|
|
BAALC
|
brain and acute leukemia, cytoplasmic
|
|
BACE1
|
beta-site APP-cleaving enzyme 1
|
|
BAK1
|
BCL2-antagonist/killer 1
|
|
BAMBI
|
BMP and activin membrane-bound inhibitor
|
|
BAX
|
BCL2-associated X protein
|
|
BBC3
|
BCL2 binding component 3
|
|
BBS4
|
Bardet-Biedl syndrome 4
|
|
BCL2
|
B-cell CLL/lymphoma 2
|
|
BCL2L1
|
BCL2-like 1
|
|
BCL2L11
|
BCL2-like 11 (apoptosis facilitator)
|
|
BCL6
|
B-cell CLL/lymphoma 6
|
|
BCR
|
breakpoint cluster region
|
|
BDNF
|
brain-derived neurotrophic factor
|
|
BIN1
|
bridging integrator 1
|
|
BIRC5
|
baculoviral IAP repeat containing 5
|
|
BLK
|
BLK proto-oncogene, Src family tyrosine kinase
|
|
BMI1
|
BMI1 proto-oncogene, polycomb ring finger
|
|
BMP2
|
bone morphogenetic protein 2
|
|
BMP6
|
bone morphogenetic protein 6
|
|
BPTF
|
bromodomain PHD finger transcription factor
|
|
BRAF
|
B-Raf proto-oncogene, serine/threonine kinase
|
|
BRCA1
|
breast cancer 1, early onset
|
|
BRCA2
|
breast cancer 2, early onset
|
|
BRIP1
|
BRCA1 interacting protein C-terminal helicase 1
|
|
BRS3
|
bombesin-like receptor 3
|
|
BTBD3
|
BTB (POZ) domain containing 3
|
|
BTK
|
Bruton agammaglobulinemia tyrosine kinase
|
|
C2ORF71
|
chromosome 2 open reading frame 71
|
|
C3
|
complement component 3
|
|
CA12
|
carbonic anhydrase XII
|
|
CA6
|
carbonic anhydrase VI
|
|
CA9
|
carbonic anhydrase IX
|
|
CACNA1A
|
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit
|
|
CACNA1C
|
calcium channel, voltage-dependent, L type, alpha 1C subunit
|
|
CADM1
|
cell adhesion molecule 1
|
|
CALM1
|
calmodulin 1 (phosphorylase kinase, delta)
|
|
CAPN10
|
calpain 10
|
|
CARD11
|
caspase recruitment domain family, member 11
|
|
CASP3
|
caspase 3, apoptosis-related cysteine peptidase
|
|
CASP4
|
caspase 4, apoptosis-related cysteine peptidase
|
|
CASP6
|
caspase 6, apoptosis-related cysteine peptidase
|
|
CASP7
|
caspase 7, apoptosis-related cysteine peptidase
|
|
CASP8
|
caspase 8, apoptosis-related cysteine peptidase
|
|
CASP8AP2
|
caspase 8 associated protein 2
|
|
CASP9
|
caspase 9, apoptosis-related cysteine peptidase
|
|
CAV1
|
caveolin 1, caveolae protein, 22kDa
|
|
CAV2
|
caveolin 2
|
|
CBS
|
cystathionine-beta-synthase
|
|
CCL1
|
chemokine (C-C motif) ligand 1
|
|
CCL11
|
chemokine (C-C motif) ligand 11
|
|
CCL17
|
chemokine (C-C motif) ligand 17
|
|
CCL18
|
chemokine (C-C motif) ligand 18 (pulmonary and activation-regulated)
|
|
CCL2
|
chemokine (C-C motif) ligand 2
|
|
CCL5
|
chemokine (C-C motif) ligand 5
|
|
CCND1
|
cyclin D1
|
|
CCND2
|
cyclin D2
|
|
CCNE1
|
cyclin E1
|
|
CCR2
|
chemokine (C-C motif) receptor 2
|
|
CCR5
|
chemokine (C-C motif) receptor 5 (gene/pseudogene)
|
|
CCR7
|
chemokine (C-C motif) receptor 7
|
|
CCR8
|
chemokine (C-C motif) receptor 8
|
|
CD14
|
CD14 molecule
|
|
CD151
|
CD151 molecule (Raph blood group)
|
|
CD209
|
CD209 molecule
|
|
CD226
|
CD226 molecule
|
|
CD24
|
CD24 molecule
|
|
CD244
|
CD244 molecule, natural killer cell receptor 2B4
|
|
CD27
|
CD27 molecule
|
|
CD34
|
CD34 molecule
|
|
CD38
|
CD38 molecule
|
|
CD3D
|
CD3d molecule, delta (CD3-TCR complex)
|
|
CD3G
|
CD3g molecule, gamma (CD3-TCR complex)
|
|
CD40LG
|
CD40 ligand
|
|
CD44
|
CD44 molecule (Indian blood group)
|
|
CD46
|
CD46 molecule, complement regulatory protein
|
|
CD68
|
CD68 molecule
|
|
CD69
|
CD69 molecule
|
|
CD74
|
CD74 molecule, major histocompatibility complex, class II invariant chain
|
|
CD81
|
CD81 molecule
|
|
CDC42
|
cell division cycle 42
|
|
CDC6
|
cell division cycle 6
|
|
CDH1
|
cadherin 1, type 1, E-cadherin (epithelial)
|
|
CDH13
|
cadherin 13
|
|
CDK2
|
cyclin-dependent kinase 2
|
|
CDK2AP1
|
cyclin-dependent kinase 2 associated protein 1
|
|
CDK4
|
cyclin-dependent kinase 4
|
|
CDK6
|
cyclin-dependent kinase 6
|
|
CDKN1A
|
cyclin-dependent kinase inhibitor 1A (p21, Cip1)
|
|
CDKN1B
|
cyclin-dependent kinase inhibitor 1B (p27, Kip1)
|
|
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2)
|
|
CDKN2A
|
cyclin-dependent kinase inhibitor 2A
|
|
CDT1
|
chromatin licensing and DNA replication factor 1
|
|
CEACAM1
|
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein)
|
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5
|
|
CEACAM6
|
carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen)
|
|
CEP250
|
centrosomal protein 250kDa
|
|
CETP
|
cholesteryl ester transfer protein, plasma
|
|
CFB
|
complement factor B
|
|
CFH
|
complement factor H
|
|
CFLAR
|
CASP8 and FADD-like apoptosis regulator
|
|
CFTR
|
cystic fibrosis transmembrane conductance regulator (ATP-binding cassette sub-family C, member 7)
|
|
CGB
|
chorionic gonadotropin, beta polypeptide
|
|
CGB5
|
chorionic gonadotropin, beta polypeptide 5
|
|
CHAT
|
choline O-acetyltransferase
|
|
CHD7
|
chromodomain helicase DNA binding protein 7
|
|
CHEK1
|
checkpoint kinase 1
|
|
CHEK2
|
checkpoint kinase 2
|
|
CHEK2P2
|
checkpoint kinase 2 pseudogene 2
|
|
CHGA
|
chromogranin A
|
|
CHKA
|
choline kinase alpha
|
|
CHPF2
|
chondroitin polymerizing factor 2
|
|
CHRNA3
|
cholinergic receptor, nicotinic, alpha 3 (neuronal)
|
|
CHRNA5
|
cholinergic receptor, nicotinic, alpha 5 (neuronal)
|
|
CHUK
|
conserved helix-loop-helix ubiquitous kinase
|
|
CITED2
|
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2
|
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
CLDN1
|
claudin 1
|
|
CLDN5
|
claudin 5
|
|
CLDN8
|
claudin 8
|
|
CLEC4M
|
C-type lectin domain family 4, member M
|
|
CLOCK
|
clock circadian regulator
|
|
CLPTM1L
|
CLPTM1-like
|
|
CMTM1
|
CKLF-like MARVEL transmembrane domain containing 1
|
|
CMTM2
|
CKLF-like MARVEL transmembrane domain containing 2
|
|
CMTM3
|
CKLF-like MARVEL transmembrane domain containing 3
|
|
CMTM4
|
CKLF-like MARVEL transmembrane domain containing 4
|
|
CMTM5
|
CKLF-like MARVEL transmembrane domain containing 5
|
|
CMTM6
|
CKLF-like MARVEL transmembrane domain containing 6
|
|
CMTM7
|
CKLF-like MARVEL transmembrane domain containing 7
|
|
CMTM8
|
CKLF-like MARVEL transmembrane domain containing 8
|
|
CNNM4
|
cyclin and CBS domain divalent metal cation transport mediator 4
|
|
COL1A1
|
collagen, type I, alpha 1
|
|
COL3A1
|
collagen, type III, alpha 1
|
|
COL4A3
|
collagen, type IV, alpha 3 (Goodpasture antigen)
|
|
COL4A5
|
collagen, type IV, alpha 5
|
|
COMT
|
catechol-O-methyltransferase
|
|
CREBBP
|
CREB binding protein
|
|
CRLF2
|
cytokine receptor-like factor 2
|
|
CRP
|
C-reactive protein, pentraxin-related
|
|
CRTC1
|
CREB regulated transcription coactivator 1
|
|
CRX
|
cone-rod homeobox
|
|
CRYGD
|
crystallin, gamma D
|
|
CSF1
|
colony stimulating factor 1 (macrophage)
|
|
CSF2
|
colony stimulating factor 2 (granulocyte-macrophage)
|
|
CSNK2A1
|
casein kinase 2, alpha 1 polypeptide
|
|
CST3
|
cystatin C
|
|
CTBP1
|
C-terminal binding protein 1
|
|
CTBP2
|
C-terminal binding protein 2
|
|
CTLA4
|
cytotoxic T-lymphocyte-associated protein 4
|
|
CTNNB1
|
catenin (cadherin-associated protein), beta 1, 88kDa
|
|
CTSB
|
cathepsin B
|
|
CTSD
|
cathepsin D
|
|
CTSK
|
cathepsin K
|
|
CTSL
|
cathepsin L
|
|
CX3CL1
|
chemokine (C-X3-C motif) ligand 1
|
|
CXCL10
|
chemokine (C-X-C motif) ligand 10
|
|
CXCL12
|
chemokine (C-X-C motif) ligand 12
|
|
CXCL16
|
chemokine (C-X-C motif) ligand 16
|
|
CXCL8
|
chemokine (C-X-C motif) ligand 8
|
|
CXCR1
|
chemokine (C-X-C motif) receptor 1
|
|
CXCR4
|
chemokine (C-X-C motif) receptor 4
|
|
CYCS
|
cytochrome c, somatic
|
|
CYP11B2
|
cytochrome P450, family 11, subfamily B, polypeptide 2
|
|
CYP17A1
|
cytochrome P450, family 17, subfamily A, polypeptide 1
|
|
CYP19A1
|
cytochrome P450, family 19, subfamily A, polypeptide 1
|
|
CYP1A1
|
cytochrome P450, family 1, subfamily A, polypeptide 1
|
|
CYP1A2
|
cytochrome P450, family 1, subfamily A, polypeptide 2
|
|
CYP1B1
|
cytochrome P450, family 1, subfamily B, polypeptide 1
|
|
CYP21A2
|
cytochrome P450, family 21, subfamily A, polypeptide 2
|
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1
|
|
CYP2A6
|
cytochrome P450, family 2, subfamily A, polypeptide 6
|
|
CYP2B6
|
cytochrome P450, family 2, subfamily B, polypeptide 6
|
|
CYP2C19
|
cytochrome P450, family 2, subfamily C, polypeptide 19
|
|
CYP2C9
|
cytochrome P450, family 2, subfamily C, polypeptide 9
|
|
CYP2D6
|
cytochrome P450, family 2, subfamily D, polypeptide 6
|
|
CYP2E1
|
cytochrome P450, family 2, subfamily E, polypeptide 1
|
|
CYP3A4
|
cytochrome P450, family 3, subfamily A, polypeptide 4
|
|
CYTL1
|
cytokine-like 1
|
|
DAG1
|
dystroglycan 1 (dystrophin-associated glycoprotein 1)
|
|
DCC
|
DCC netrin 1 receptor
|
|
DCK
|
deoxycytidine kinase
|
|
DCLK1
|
doublecortin-like kinase 1
|
|
DCN
|
decorin
|
|
DDIT3
|
DNA-damage-inducible transcript 3
|
|
DEFA4
|
defensin, alpha 4, corticostatin
|
|
DFFA
|
DNA fragmentation factor, 45kDa, alpha polypeptide
|
|
DHCR7
|
7-dehydrocholesterol reductase
|
|
DIABLO
|
diablo, IAP-binding mitochondrial protein
|
|
DIO2
|
deiodinase, iodothyronine, type II
|
|
DLC1
|
DLC1 Rho GTPase activating protein
|
|
DLL4
|
delta-like 4 (Drosophila)
|
|
DMD
|
dystrophin
|
|
DMKN
|
dermokine
|
|
DNAJB2
|
DnaJ (Hsp40) homolog, subfamily B, member 2
|
|
DNM1L
|
dynamin 1-like
|
|
DNMT1
|
DNA (cytosine-5-)-methyltransferase 1
|
|
DPP4
|
dipeptidyl-peptidase 4
|
|
DPPA4
|
developmental pluripotency associated 4
|
|
DRD4
|
dopamine receptor D4
|
|
DSP
|
desmoplakin
|
|
DTYMK
|
deoxythymidylate kinase (thymidylate kinase)
|
|
DUOX2
|
dual oxidase 2
|
|
ECE1
|
endothelin converting enzyme 1
|
|
EDN1
|
endothelin 1
|
|
EDNRA
|
endothelin receptor type A
|
|
EFHC1
|
EF-hand domain (C-terminal) containing 1
|
|
EFNB1
|
ephrin-B1
|
|
EFNB2
|
ephrin-B2
|
|
EGF
|
epidermal growth factor
|
|
EGFL7
|
EGF-like-domain, multiple 7
|
|
EGFR
|
epidermal growth factor receptor
|
|
EGR1
|
early growth response 1
|
|
EIF2A
|
eukaryotic translation initiation factor 2A, 65kDa
|
|
EIF2AK2
|
eukaryotic translation initiation factor 2-alpha kinase 2
|
|
EIF2B5
|
eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa
|
|
EIF4EBP1
|
eukaryotic translation initiation factor 4E binding protein 1
|
|
ELF1
|
E74-like factor 1 (ets domain transcription factor)
|
|
ELK1
|
ELK1, member of ETS oncogene family
|
|
EMD
|
emerin
|
|
ENG
|
endoglin
|
|
ENO2
|
enolase 2 (gamma, neuronal)
|
|
EP300
|
E1A binding protein p300
|
|
EPB41L3
|
erythrocyte membrane protein band 4.1-like 3
|
|
EPCAM
|
epithelial cell adhesion molecule
|
|
EPHB3
|
EPH receptor B3
|
|
EPHB6
|
EPH receptor B6
|
|
EPHX1
|
epoxide hydrolase 1, microsomal (xenobiotic)
|
|
EPHX2
|
epoxide hydrolase 2, cytoplasmic
|
|
EPOR
|
erythropoietin receptor
|
|
ERBB2
|
erb-b2 receptor tyrosine kinase 2
|
|
ERBB3
|
erb-b2 receptor tyrosine kinase 3
|
|
ERCC1
|
excision repair cross-complementation group 1
|
|
ERCC2
|
excision repair cross-complementation group 2
|
|
ERCC3
|
excision repair cross-complementation group 3
|
|
ERCC5
|
excision repair cross-complementation group 5
|
|
ERG
|
v-ets avian erythroblastosis virus E26 oncogene homolog
|
|
ESR1
|
estrogen receptor 1
|
|
ESR2
|
estrogen receptor 2 (ER beta)
|
|
EZH2
|
enhancer of zeste 2 polycomb repressive complex 2 subunit
|
|
F12
|
coagulation factor XII (Hageman factor)
|
|
F2
|
coagulation factor II (thrombin)
|
|
F2R
|
coagulation factor II (thrombin) receptor
|
|
F2RL3
|
coagulation factor II (thrombin) receptor-like 3
|
|
F3
|
coagulation factor III (thromboplastin, tissue factor)
|
|
F5
|
coagulation factor V (proaccelerin, labile factor)
|
|
F7
|
coagulation factor VII (serum prothrombin conversion accelerator)
|
|
F8
|
coagulation factor VIII, procoagulant component
|
|
F9
|
coagulation factor IX
|
|
FABP1
|
fatty acid binding protein 1, liver
|
|
FABP3
|
fatty acid binding protein 3, muscle and heart
|
|
FAF1
|
Fas (TNFRSF6) associated factor 1
|
|
FAM167A
|
family with sequence similarity 167, member A
|
|
FANCA
|
Fanconi anemia, complementation group A
|
|
FAS
|
Fas cell surface death receptor
|
|
FASLG
|
Fas ligand (TNF superfamily, member 6)
|
|
FCER1A
|
Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide
|
|
FCER1G
|
Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide
|
|
FCER2
|
Fc fragment of IgE, low affinity II, receptor for (CD23)
|
|
FCGR1A
|
Fc fragment of IgG, high affinity Ia, receptor (CD64)
|
|
FCGR2A
|
Fc fragment of IgG, low affinity IIa, receptor (CD32)
|
|
FCGR3A
|
Fc fragment of IgG, low affinity IIIa, receptor (CD16a)
|
|
FCGR3B
|
Fc fragment of IgG, low affinity IIIb, receptor (CD16b)
|
|
FECD3
|
Corneal dystrophy, Fuchs endothelial, 3
|
|
FFAR4
|
free fatty acid receptor 4
|
|
FGF2
|
fibroblast growth factor 2 (basic)
|
|
FGF23
|
fibroblast growth factor 23
|
|
FGFR1
|
fibroblast growth factor receptor 1
|
|
FGFR3
|
fibroblast growth factor receptor 3
|
|
FGL1
|
fibrinogen-like 1
|
|
FKBP5
|
FK506 binding protein 5
|
|
FLG
|
filaggrin
|
|
FLT1
|
fms-related tyrosine kinase 1
|
|
FLT3
|
fms-related tyrosine kinase 3
|
|
FLT3LG
|
fms-related tyrosine kinase 3 ligand
|
|
FLT4
|
fms-related tyrosine kinase 4
|
|
FMO3
|
flavin containing monooxygenase 3
|
|
FMR1
|
fragile X mental retardation 1
|
|
FOXM1
|
forkhead box M1
|
|
FOXO1
|
forkhead box O1
|
|
FOXO3
|
forkhead box O3
|
|
FOXP3
|
forkhead box P3
|
|
FRS2
|
fibroblast growth factor receptor substrate 2
|
|
FSCN1
|
fascin actin-bundling protein 1
|
|
FSHB
|
follicle stimulating hormone, beta polypeptide
|
|
FSHR
|
follicle stimulating hormone receptor
|
|
FTL
|
ferritin, light polypeptide
|
|
FTO
|
fat mass and obesity associated
|
|
FUT4
|
fucosyltransferase 4 (alpha (1,3) fucosyltransferase, myeloid-specific)
|
|
FXYD5
|
FXYD domain containing ion transport regulator 5
|
|
GABPA
|
GA binding protein transcription factor, alpha subunit 60kDa
|
|
GATA3
|
GATA binding protein 3
|
|
GATA4
|
GATA binding protein 4
|
|
GBA
|
glucosidase, beta, acid
|
|
GCH1
|
GTP cyclohydrolase 1
|
|
GCK
|
glucokinase (hexokinase 4)
|
|
GDF15
|
growth differentiation factor 15
|
|
GDNF
|
glial cell derived neurotrophic factor
|
|
GGT1
|
gamma-glutamyltransferase 1
|
|
GH1
|
growth hormone 1
|
|
GHSR
|
growth hormone secretagogue receptor
|
|
GJA1
|
gap junction protein, alpha 1, 43kDa
|
|
GLI1
|
GLI family zinc finger 1
|
|
GLO1
|
glyoxalase I
|
|
GLS2
|
glutaminase 2 (liver, mitochondrial)
|
|
GMNN
|
geminin, DNA replication inhibitor
|
|
GNAI1
|
guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 1
|
|
GNAS
|
GNAS complex locus
|
|
GNB3
|
guanine nucleotide binding protein (G protein), beta polypeptide 3
|
|
GNRH1
|
gonadotropin-releasing hormone 1 (luteinizing-releasing hormone)
|
|
GOLM1
|
golgi membrane protein 1
|
|
GPBAR1
|
G protein-coupled bile acid receptor 1
|
|
GPC3
|
glypican 3
|
|
GPR132
|
G protein-coupled receptor 132
|
|
GPX1
|
glutathione peroxidase 1
|
|
GRB7
|
growth factor receptor-bound protein 7
|
|
GRIA1
|
glutamate receptor, ionotropic, AMPA 1
|
|
GRN
|
granulin
|
|
GSDMB
|
gasdermin B
|
|
GSK3B
|
glycogen synthase kinase 3 beta
|
|
GSTA1
|
glutathione S-transferase alpha 1
|
|
GSTM1
|
glutathione S-transferase mu 1
|
|
GSTM2
|
glutathione S-transferase mu 2 (muscle)
|
|
GSTP1
|
glutathione S-transferase pi 1
|
|
GSTT1
|
glutathione S-transferase theta 1
|
|
GSTZ1
|
glutathione S-transferase zeta 1
|
|
GTF2H4
|
general transcription factor IIH, polypeptide 4, 52kDa
|
|
GUCY1A2
|
guanylate cyclase 1, soluble, alpha 2
|
|
GUSB
|
glucuronidase, beta
|
|
H2AFX
|
H2A histone family, member X
|
|
HAMP
|
hepcidin antimicrobial peptide
|
|
HAP1
|
huntingtin-associated protein 1
|
|
HBA2
|
hemoglobin, alpha 2
|
|
HDAC2
|
histone deacetylase 2
|
|
HDAC4
|
histone deacetylase 4
|
|
HDAC6
|
histone deacetylase 6
|
|
HFE
|
hemochromatosis
|
|
HGF
|
hepatocyte growth factor (hepapoietin A; scatter factor)
|
|
HIF1A
|
hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)
|
|
HLA-A
|
major histocompatibility complex, class I, A
|
|
HLA-B
|
major histocompatibility complex, class I, B
|
|
HLA-C
|
major histocompatibility complex, class I, C
|
|
HLA-DQA1
|
major histocompatibility complex, class II, DQ alpha 1
|
|
HLA-DQB1
|
major histocompatibility complex, class II, DQ beta 1
|
|
HLA-DRB1
|
major histocompatibility complex, class II, DR beta 1
|
|
HLA-E
|
major histocompatibility complex, class I, E
|
|
HLA-G
|
major histocompatibility complex, class I, G
|
|
HLX
|
H2.0-like homeobox
|
|
HMBS
|
hydroxymethylbilane synthase
|
|
HMGB1
|
high mobility group box 1
|
|
HMGB2
|
high mobility group box 2
|
|
HMOX1
|
heme oxygenase 1
|
|
HNF1A
|
HNF1 homeobox A
|
|
HNF4A
|
hepatocyte nuclear factor 4, alpha
|
|
HOXA1
|
homeobox A1
|
|
HOXA4
|
homeobox A4
|
|
HOXB4
|
homeobox B4
|
|
HOXB7
|
homeobox B7
|
|
HPGD
|
hydroxyprostaglandin dehydrogenase 15-(NAD)
|
|
HPSE
|
heparanase
|
|
HRAS
|
Harvey rat sarcoma viral oncogene homolog
|
|
HRG
|
histidine-rich glycoprotein
|
|
HSD17B4
|
hydroxysteroid (17-beta) dehydrogenase 4
|
|
HSF1
|
heat shock transcription factor 1
|
|
HSP90AA1
|
heat shock protein 90kDa alpha (cytosolic), class A member 1
|
|
HSPA1A
|
heat shock 70kDa protein 1A
|
|
HSPA4
|
heat shock 70kDa protein 4
|
|
HSPA5
|
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)
|
|
HSPB1
|
heat shock 27kDa protein 1
|
|
HSPE1
|
heat shock 10kDa protein 1
|
|
HTR1A
|
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled
|
|
IAPP
|
islet amyloid polypeptide
|
|
ICAM1
|
intercellular adhesion molecule 1
|
|
IDE
|
insulin-degrading enzyme
|
|
IDH1
|
isocitrate dehydrogenase 1 (NADP+), soluble
|
|
IDH2
|
isocitrate dehydrogenase 2 (NADP+), mitochondrial
|
|
IDO1
|
indoleamine 2,3-dioxygenase 1
|
|
IFNA1
|
interferon, alpha 1
|
|
IFNA2
|
interferon, alpha 2
|
|
IFNAR1
|
interferon (alpha, beta and omega) receptor 1
|
|
IFNB1
|
interferon, beta 1, fibroblast
|
|
IFNG
|
interferon, gamma
|
|
IFNGR1
|
interferon gamma receptor 1
|
|
IFNGR2
|
interferon gamma receptor 2 (interferon gamma transducer 1)
|
|
IFNL3
|
interferon, lambda 3
|
|
IGF1
|
insulin-like growth factor 1 (somatomedin C)
|
|
IGF1R
|
insulin-like growth factor 1 receptor
|
|
IGF2
|
insulin-like growth factor 2
|
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3
|
|
IGF2R
|
insulin-like growth factor 2 receptor
|
|
IGFBP2
|
insulin-like growth factor binding protein 2, 36kDa
|
|
IGFBP3
|
insulin-like growth factor binding protein 3
|
|
IGH
|
immunoglobulin heavy locus
|
|
IGHG1
|
immunoglobulin heavy constant gamma 1 (G1m marker)
|
|
IKBKB
|
inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta
|
|
IL10
|
interleukin 10
|
|
IL10RA
|
interleukin 10 receptor, alpha
|
|
IL10RB
|
interleukin 10 receptor, beta
|
|
IL12B
|
interleukin 12B
|
|
IL13
|
interleukin 13
|
|
IL13RA1
|
interleukin 13 receptor, alpha 1
|
|
IL15
|
interleukin 15
|
|
IL17A
|
interleukin 17A
|
|
IL17F
|
interleukin 17F
|
|
IL17RA
|
interleukin 17 receptor A
|
|
IL17RC
|
interleukin 17 receptor C
|
|
IL18
|
interleukin 18
|
|
IL1A
|
interleukin 1, alpha
|
|
IL1B
|
interleukin 1, beta
|
|
IL1R1
|
interleukin 1 receptor, type I
|
|
IL1RN
|
interleukin 1 receptor antagonist
|
|
IL2
|
interleukin 2
|
|
IL22
|
interleukin 22
|
|
IL23R
|
interleukin 23 receptor
|
|
IL24
|
interleukin 24
|
|
IL27
|
interleukin 27
|
|
IL2RA
|
interleukin 2 receptor, alpha
|
|
IL33R
|
interleukin 33 receptor
|
|
IL4
|
interleukin 4
|
|
IL4R
|
interleukin 4 receptor
|
|
IL5
|
interleukin 5
|
|
IL6
|
interleukin 6
|
|
IL9R
|
interleukin 9 receptor
|
|
IMP3
|
IMP3, U3 small nucleolar ribonucleoprotein
|
|
INPP4B
|
inositol polyphosphate-4-phosphatase, type II, 105kDa
|
|
INPP5D
|
inositol polyphosphate-5-phosphatase, 145kDa
|
|
INPPL1
|
inositol polyphosphate phosphatase-like 1
|
|
INSIG2
|
insulin induced gene 2
|
|
INSR
|
insulin receptor
|
|
IPO5
|
importin 5
|
|
IRF1
|
interferon regulatory factor 1
|
|
IRF3
|
interferon regulatory factor 3
|
|
IRF7
|
interferon regulatory factor 7
|
|
IRS1
|
insulin receptor substrate 1
|
|
IRS2
|
insulin receptor substrate 2
|
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
ITGA3
|
integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor)
|
|
ITGA9
|
integrin, alpha 9
|
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide)
|
|
ITGAM
|
integrin, alpha M (complement component 3 receptor 3 subunit)
|
|
ITGAV
|
integrin, alpha V
|
|
ITGAX
|
integrin, alpha X (complement component 3 receptor 4 subunit)
|
|
ITGB1
|
integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)
|
|
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit)
|
|
ITGB3
|
integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)
|
|
ITLN1
|
intelectin 1 (galactofuranose binding)
|
|
ITPA
|
inosine triphosphatase (nucleoside triphosphate pyrophosphatase)
|
|
JAK1
|
Janus kinase 1
|
|
JAK2
|
Janus kinase 2
|
|
JUN
|
jun proto-oncogene
|
|
JUP
|
junction plakoglobin
|
|
KCNA1
|
potassium channel, voltage gated shaker related subfamily A, member 1
|
|
KCNA5
|
potassium channel, voltage gated shaker related subfamily A, member 5
|
|
KCNH2
|
potassium channel, voltage gated eag related subfamily H, member 2
|
|
KCNJ5
|
potassium channel, inwardly rectifying subfamily J, member 5
|
|
KDR
|
kinase insert domain receptor
|
|
KIF11
|
kinesin family member 11
|
|
KIF2C
|
kinesin family member 2C
|
|
KIF6
|
kinesin family member 6
|
|
KIR2DL1
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1
|
|
KIR2DL2
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2
|
|
KIR2DL3
|
killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3
|
|
KIR2DS1
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1
|
|
KIR2DS2
|
killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 2
|
|
KIR3DL1
|
killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1
|
|
KIR3DS1
|
killer cell immunoglobulin-like receptor, three domains, short cytoplasmic tail, 1
|
|
KISS1
|
KiSS-1 metastasis-suppressor
|
|
KISS1R
|
KISS1 receptor
|
|
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog
|
|
KITLG
|
KIT ligand
|
|
KLF4
|
Kruppel-like factor 4 (gut)
|
|
KLF6
|
Kruppel-like factor 6
|
|
KLK1
|
kallikrein 1
|
|
KLK10
|
kallikrein-related peptidase 10
|
|
KLK13
|
kallikrein-related peptidase 13
|
|
KLK14
|
kallikrein-related peptidase 14
|
|
KLK2
|
kallikrein-related peptidase 2
|
|
KLK3
|
kallikrein-related peptidase 3
|
|
KLK5
|
kallikrein-related peptidase 5
|
|
KLK6
|
kallikrein-related peptidase 6
|
|
KLK7
|
kallikrein-related peptidase 7
|
|
KLK8
|
kallikrein-related peptidase 8
|
|
KPNA3
|
karyopherin alpha 3 (importin alpha 4)
|
|
KRAS
|
Kirsten rat sarcoma viral oncogene homolog
|
|
KRT10
|
keratin 10, type I
|
|
KRT19
|
keratin 19, type I
|
|
KRT20
|
keratin 20, type I
|
|
KRT5
|
keratin 5, type II
|
|
KRT7
|
keratin 7, type II
|
|
L1CAM
|
L1 cell adhesion molecule
|
|
LAMC2
|
laminin, gamma 2
|
|
LARP7
|
La ribonucleoprotein domain family, member 7
|
|
LCN2
|
lipocalin 2
|
|
LDHA
|
lactate dehydrogenase A
|
|
LDLR
|
low density lipoprotein receptor
|
|
LECT1
|
leukocyte cell derived chemotaxin 1
|
|
LEP
|
leptin
|
|
LEPR
|
leptin receptor
|
|
LGALS1
|
lectin, galactoside-binding, soluble, 1
|
|
LGALS3
|
lectin, galactoside-binding, soluble, 3
|
|
LHX3
|
LIM homeobox 3
|
|
LIF
|
leukemia inhibitory factor
|
|
LIG4
|
ligase IV, DNA, ATP-dependent
|
|
LIPA
|
lipase A, lysosomal acid, cholesterol esterase
|
|
LIPC
|
lipase, hepatic
|
|
LIPE
|
lipase, hormone-sensitive
|
|
LIPH
|
lipase, member H
|
|
LITAF
|
lipopolysaccharide-induced TNF factor
|
|
LMNA
|
lamin A/C
|
|
LPCAT1
|
lysophosphatidylcholine acyltransferase 1
|
|
LSM11
|
LSM11, U7 small nuclear RNA associated
|
|
LTA
|
lymphotoxin alpha
|
|
LTC4S
|
leukotriene C4 synthase
|
|
LTF
|
lactotransferrin
|
|
LUM
|
lumican
|
|
MAFG
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog G
|
|
MAFK
|
v-maf avian musculoaponeurotic fibrosarcoma oncogene homolog K
|
|
MAL
|
mal, T-cell differentiation protein
|
|
MAOA
|
monoamine oxidase A
|
|
MAOB
|
monoamine oxidase B
|
|
MAP2K1
|
mitogen-activated protein kinase kinase 1
|
|
MAP2K2
|
mitogen-activated protein kinase kinase 2
|
|
MAP2K7
|
mitogen-activated protein kinase kinase 7
|
|
MAP3K14
|
mitogen-activated protein kinase kinase kinase 14
|
|
MAPK1
|
mitogen-activated protein kinase 1
|
|
MAPK14
|
mitogen-activated protein kinase 14
|
|
MAPK3
|
mitogen-activated protein kinase 3
|
|
MAPK7
|
mitogen-activated protein kinase 7
|
|
MAPK8
|
mitogen-activated protein kinase 8
|
|
MAPT
|
microtubule-associated protein tau
|
|
MBD2
|
methyl-CpG binding domain protein 2
|
|
MBL2
|
mannose-binding lectin (protein C) 2, soluble
|
|
MC4R
|
melanocortin 4 receptor
|
|
MCL1
|
myeloid cell leukemia 1
|
|
MCM10
|
minichromosome maintenance complex component 10
|
|
MCM2
|
minichromosome maintenance complex component 2
|
|
MDM2
|
MDM2 proto-oncogene, E3 ubiquitin protein ligase
|
|
MDM4
|
MDM4, p53 regulator
|
|
MED12
|
mediator complex subunit 12
|
|
MEIS1
|
Meis homeobox 1
|
|
MEP1A
|
meprin A, alpha (PABA peptide hydrolase)
|
|
MET
|
MET proto-oncogene, receptor tyrosine kinase
|
|
MEX3C
|
mex-3 RNA binding family member C
|
|
MGAT1
|
mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase
|
|
MGAT5
|
mannosyl (alpha-1,6-)-glycoprotein beta-1,6-N-acetyl-glucosaminyltransferase
|
|
MGMT
|
O-6-methylguanine-DNA methyltransferase
|
|
MIA
|
melanoma inhibitory activity
|
|
MICA
|
MHC class I polypeptide-related sequence A
|
|
MIF
|
macrophage migration inhibitory factor (glycosylation-inhibiting factor)
|
|
MIR125A
|
microRNA 125a
|
|
MIR125B1
|
microRNA 125b-1
|
|
MIR146A
|
microRNA 146a
|
|
MIR149
|
microRNA 149
|
|
MIR16-1
|
microRNA 16-1
|
|
MIR17
|
microRNA 17
|
|
MIR181C
|
microRNA 181c
|
|
MIR190A
|
microRNA 190a
|
|
MIR191
|
microRNA 191
|
|
MIR196A2
|
microRNA 196a-2
|
|
MIR200A
|
microRNA 200a
|
|
MIR21
|
microRNA 21
|
|
MIR217
|
microRNA 217
|
|
MIR221
|
microRNA 221
|
|
MIR222
|
microRNA 222
|
|
MIR34B
|
microRNA 34b
|
|
MIR375
|
microRNA 375
|
|
MIR377
|
microRNA 377
|
|
MIR499A
|
microRNA 499a
|
|
MIR95
|
microRNA 95
|
|
MITF
|
microphthalmia-associated transcription factor
|
|
MKI67
|
marker of proliferation Ki-67
|
|
MLH1
|
mutL homolog 1
|
|
MME
|
membrane metallo-endopeptidase
|
|
MMP1
|
matrix metallopeptidase 1
|
|
MMP14
|
matrix metallopeptidase 14 (membrane-inserted)
|
|
MMP2
|
matrix metallopeptidase 2
|
|
MMP3
|
matrix metallopeptidase 3
|
|
MMP9
|
matrix metallopeptidase 9
|
|
MPO
|
myeloperoxidase
|
|
MRE11A
|
MRE11 meiotic recombination 11 homolog A (S. cerevisiae)
|
|
MS4A1
|
membrane-spanning 4-domains, subfamily A, member 1
|
|
MSH2
|
mutS homolog 2
|
|
MSH6
|
mutS homolog 6
|
|
MSLN
|
mesothelin
|
|
MST1R
|
macrophage stimulating 1 receptor
|
|
MTDH
|
metadherin
|
|
MTHFR
|
methylenetetrahydrofolate reductase (NAD(P)H)
|
|
MTOR
|
mechanistic target of rapamycin (serine/threonine kinase)
|
|
MTR
|
5-methyltetrahydrofolate-homocysteine methyltransferase
|
|
MUC1
|
mucin 1, cell surface associated
|
|
MUC16
|
mucin 16, cell surface associated
|
|
MUC5AC
|
mucin 5AC, oligomeric mucus/gel-forming
|
|
MX2
|
MX dynamin-like GTPase 2
|
|
MYBBP1A
|
MYB binding protein (P160) 1a
|
|
MYBPC3
|
myosin binding protein C, cardiac
|
|
MYC
|
v-myc avian myelocytomatosis viral oncogene homolog
|
|
MYCN
|
v-myc avian myelocytomatosis viral oncogene neuroblastoma derived homolog
|
|
MYH9
|
myosin, heavy chain 9, non-muscle
|
|
NAA10
|
N(alpha)-acetyltransferase 10, NatA catalytic subunit
|
|
NANOG
|
Nanog homeobox
|
|
NAPSA
|
napsin A aspartic peptidase
|
|
NAT1
|
N-acetyltransferase 1 (arylamine N-acetyltransferase)
|
|
NAT2
|
N-acetyltransferase 2 (arylamine N-acetyltransferase)
|
|
NCK1
|
NCK adaptor protein 1
|
|
NCOA2
|
nuclear receptor coactivator 2
|
|
NCOA3
|
nuclear receptor coactivator 3
|
|
NEDD1
|
neural precursor cell expressed, developmentally down-regulated 1
|
|
NEDD4
|
neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase
|
|
NES
|
nestin
|
|
NET1
|
neuroepithelial cell transforming 1
|
|
NEUROD1
|
neuronal differentiation 1
|
|
NEWENTRY
|
Record to support submission of GeneRIFs for a gene not in Gene (human; man).
|
|
NF1
|
neurofibromin 1
|
|
NF2
|
neurofibromin 2 (merlin)
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
NFE2
|
nuclear factor, erythroid 2
|
|
NFE2L2
|
nuclear factor, erythroid 2-like 2
|
|
NFKB1
|
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1
|
|
NGFR
|
nerve growth factor receptor
|
|
NKX2-1
|
NK2 homeobox 1
|
|
NME1
|
NME/NM23 nucleoside diphosphate kinase 1
|
|
NMNAT1
|
nicotinamide nucleotide adenylyltransferase 1
|
|
NOD1
|
nucleotide-binding oligomerization domain containing 1
|
|
NOD2
|
nucleotide-binding oligomerization domain containing 2
|
|
NODAL
|
nodal growth differentiation factor
|
|
NOG
|
noggin
|
|
NOS2
|
nitric oxide synthase 2, inducible
|
|
NOS3
|
nitric oxide synthase 3 (endothelial cell)
|
|
NOTCH1
|
notch 1
|
|
NPM1
|
nucleophosmin (nucleolar phosphoprotein B23, numatrin)
|
|
NPPB
|
natriuretic peptide B
|
|
NQO1
|
NAD(P)H dehydrogenase, quinone 1
|
|
NR1I2
|
nuclear receptor subfamily 1, group I, member 2
|
|
NR3C1
|
nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)
|
|
NR4A1
|
nuclear receptor subfamily 4, group A, member 1
|
|
NRAS
|
neuroblastoma RAS viral (v-ras) oncogene homolog
|
|
NRG1
|
neuregulin 1
|
|
NRP1
|
neuropilin 1
|
|
NSMF
|
NMDA receptor synaptonuclear signaling and neuronal migration factor
|
|
NUCKS1
|
nuclear casein kinase and cyclin-dependent kinase substrate 1
|
|
NUDCD1
|
NudC domain containing 1
|
|
ODC1
|
ornithine decarboxylase 1
|
|
OGG1
|
8-oxoguanine DNA glycosylase
|
|
OLR1
|
oxidized low density lipoprotein (lectin-like) receptor 1
|
|
ORMDL3
|
ORMDL sphingolipid biosynthesis regulator 3
|
|
OTUD4
|
OTU deubiquitinase 4
|
|
OXTR
|
oxytocin receptor
|
|
P2RX1
|
purinergic receptor P2X, ligand gated ion channel, 1
|
|
P2RX7
|
purinergic receptor P2X, ligand gated ion channel, 7
|
|
P2RY11
|
purinergic receptor P2Y, G-protein coupled, 11
|
|
PADI4
|
peptidyl arginine deiminase, type IV
|
|
PAK1
|
p21 protein (Cdc42/Rac)-activated kinase 1
|
|
PAPPA
|
pregnancy-associated plasma protein A, pappalysin 1
|
|
PARK2
|
parkin RBR E3 ubiquitin protein ligase
|
|
PARP1
|
poly (ADP-ribose) polymerase 1
|
|
PAX2
|
paired box 2
|
|
PAX8
|
paired box 8
|
|
PBX2
|
pre-B-cell leukemia homeobox 2
|
|
PCA3
|
prostate cancer associated 3 (non-protein coding)
|
|
PCDH15
|
protocadherin-related 15
|
|
PCNA
|
proliferating cell nuclear antigen
|
|
PDCD1
|
programmed cell death 1
|
|
PDGFB
|
platelet-derived growth factor beta polypeptide
|
|
PDGFRA
|
platelet-derived growth factor receptor, alpha polypeptide
|
|
PDX1
|
pancreatic and duodenal homeobox 1
|
|
PGR
|
progesterone receptor
|
|
PIGA
|
phosphatidylinositol glycan anchor biosynthesis, class A
|
|
PIK3CA
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
|
|
PIK3CD
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit delta
|
|
PIK3CG
|
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma
|
|
PINK1
|
PTEN induced putative kinase 1
|
|
PITX2
|
paired-like homeodomain 2
|
|
PLA2G7
|
phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)
|
|
PLAT
|
plasminogen activator, tissue
|
|
PLAU
|
plasminogen activator, urokinase
|
|
PLAUR
|
plasminogen activator, urokinase receptor
|
|
PLK1
|
polo-like kinase 1
|
|
PML
|
promyelocytic leukemia
|
|
PMM2
|
phosphomannomutase 2
|
|
PMS2
|
PMS2 postmeiotic segregation increased 2 (S. cerevisiae)
|
|
PNKP
|
polynucleotide kinase 3'-phosphatase
|
|
PNLIP
|
pancreatic lipase
|
|
POLA1
|
polymerase (DNA directed), alpha 1, catalytic subunit
|
|
POLG
|
polymerase (DNA directed), gamma
|
|
PON1
|
paraoxonase 1
|
|
PON2
|
paraoxonase 2
|
|
POU2F1
|
POU class 2 homeobox 1
|
|
POU5F1
|
POU class 5 homeobox 1
|
|
PPARA
|
peroxisome proliferator-activated receptor alpha
|
|
PPARG
|
peroxisome proliferator-activated receptor gamma
|
|
PPARGC1A
|
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha
|
|
PPARGC1B
|
peroxisome proliferator-activated receptor gamma, coactivator 1 beta
|
|
PPP1R15A
|
protein phosphatase 1, regulatory subunit 15A
|
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
PRF1
|
perforin 1 (pore forming protein)
|
|
PRKAA2
|
protein kinase, AMP-activated, alpha 2 catalytic subunit
|
|
PRKAB1
|
protein kinase, AMP-activated, beta 1 non-catalytic subunit
|
|
PRKAG2
|
protein kinase, AMP-activated, gamma 2 non-catalytic subunit
|
|
PRKAR2B
|
protein kinase, cAMP-dependent, regulatory, type II, beta
|
|
PRM1
|
protamine 1
|
|
PRM2
|
protamine 2
|
|
PROCR
|
protein C receptor, endothelial
|
|
PROK1
|
prokineticin 1
|
|
PROKR1
|
prokineticin receptor 1
|
|
PROKR2
|
prokineticin receptor 2
|
|
PROM1
|
prominin 1
|
|
PROZ
|
protein Z, vitamin K-dependent plasma glycoprotein
|
|
PRSS1
|
protease, serine, 1 (trypsin 1)
|
|
PSCA
|
prostate stem cell antigen
|
|
PSEN1
|
presenilin 1
|
|
PSIP1
|
PC4 and SFRS1 interacting protein 1
|
|
PSMA3
|
proteasome (prosome, macropain) subunit, alpha type, 3
|
|
PSMB11
|
proteasome (prosome, macropain) subunit, beta type, 11
|
|
PSMD10
|
proteasome (prosome, macropain) 26S subunit, non-ATPase, 10
|
|
PTEN
|
phosphatase and tensin homolog
|
|
PTGES
|
prostaglandin E synthase
|
|
PTGES3
|
prostaglandin E synthase 3 (cytosolic)
|
|
PTGS2
|
prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)
|
|
PTK2
|
protein tyrosine kinase 2
|
|
PTN
|
pleiotrophin
|
|
PTPN11
|
protein tyrosine phosphatase, non-receptor type 11
|
|
PTPN22
|
protein tyrosine phosphatase, non-receptor type 22 (lymphoid)
|
|
PTTG1
|
pituitary tumor-transforming 1
|
|
RACGAP1
|
Rac GTPase activating protein 1
|
|
RAD17
|
RAD17 homolog (S. pombe)
|
|
RAD51
|
RAD51 recombinase
|
|
RAF1
|
Raf-1 proto-oncogene, serine/threonine kinase
|
|
RALBP1
|
ralA binding protein 1
|
|
RARB
|
retinoic acid receptor, beta
|
|
RASA1
|
RAS p21 protein activator (GTPase activating protein) 1
|
|
RASEF
|
RAS and EF-hand domain containing
|
|
RASGRP2
|
RAS guanyl releasing protein 2 (calcium and DAG-regulated)
|
|
RAX
|
retina and anterior neural fold homeobox
|
|
RB1
|
retinoblastoma 1
|
|
RCOR1
|
REST corepressor 1
|
|
REG1A
|
regenerating islet-derived 1 alpha
|
|
REG4
|
regenerating islet-derived family, member 4
|
|
REN
|
renin
|
|
REPS2
|
RALBP1 associated Eps domain containing 2
|
|
REST
|
RE1-silencing transcription factor
|
|
RET
|
ret proto-oncogene
|
|
RETN
|
resistin
|
|
RFTN1
|
raftlin, lipid raft linker 1
|
|
RGS16
|
regulator of G-protein signaling 16
|
|
RGS5
|
regulator of G-protein signaling 5
|
|
RHAG
|
Rh-associated glycoprotein
|
|
RHOF
|
ras homolog family member F (in filopodia)
|
|
RHOG
|
ras homolog family member G
|
|
RIPK1
|
receptor (TNFRSF)-interacting serine-threonine kinase 1
|
|
RNF216
|
ring finger protein 216
|
|
RNU6-1
|
RNA, U6 small nuclear 1
|
|
RPA1
|
replication protein A1, 70kDa
|
|
RPGR
|
retinitis pigmentosa GTPase regulator
|
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1
|
|
RREB1
|
ras responsive element binding protein 1
|
|
RRM1
|
ribonucleotide reductase M1
|
|
RRM2B
|
ribonucleotide reductase M2 B (TP53 inducible)
|
|
RS1
|
retinoschisin 1
|
|
RUNX1
|
runt-related transcription factor 1
|
|
RUNX1T1
|
runt-related transcription factor 1; translocated to, 1 (cyclin D-related)
|
|
RUNX3
|
runt-related transcription factor 3
|
|
RUVBL1
|
RuvB-like AAA ATPase 1
|
|
RUVBL2
|
RuvB-like AAA ATPase 2
|
|
RXRG
|
retinoid X receptor, gamma
|
|
S100A1
|
S100 calcium binding protein A1
|
|
S100A6
|
S100 calcium binding protein A6
|
|
S100A7
|
S100 calcium binding protein A7
|
|
S100A8
|
S100 calcium binding protein A8
|
|
S100A9
|
S100 calcium binding protein A9
|
|
S100B
|
S100 calcium binding protein B
|
|
SACK1A
|
scaffolding CK1 anchoring protein A
|
|
SATB2
|
SATB homeobox 2
|
|
SCD
|
stearoyl-CoA desaturase (delta-9-desaturase)
|
|
SCGB1A1
|
secretoglobin, family 1A, member 1 (uteroglobin)
|
|
SCGB2A1
|
secretoglobin, family 2A, member 1
|
|
SCGB2A2
|
secretoglobin, family 2A, member 2
|
|
SCGB3A1
|
secretoglobin, family 3A, member 1
|
|
SCLY
|
selenocysteine lyase
|
|
SCN4A
|
sodium channel, voltage gated, type IV alpha subunit
|
|
SCN5A
|
sodium channel, voltage gated, type V alpha subunit
|
|
SCN9A
|
sodium channel, voltage gated, type IX alpha subunit
|
|
SCRG1
|
stimulator of chondrogenesis 1
|
|
SDHB
|
succinate dehydrogenase complex, subunit B, iron sulfur (Ip)
|
|
SDHD
|
succinate dehydrogenase complex, subunit D, integral membrane protein
|
|
SELL
|
selectin L
|
|
SELP
|
selectin P (granule membrane protein 140kDa, antigen CD62)
|
|
SERPINA1
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1
|
|
SERPINA5
|
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5
|
|
SERPINB3
|
serpin peptidase inhibitor, clade B (ovalbumin), member 3
|
|
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1
|
|
SET
|
SET nuclear proto-oncogene
|
|
SFRP2
|
secreted frizzled-related protein 2
|
|
SH2D1A
|
SH2 domain containing 1A
|
|
SHBG
|
sex hormone-binding globulin
|
|
SHH
|
sonic hedgehog
|
|
SHOX
|
short stature homeobox
|
|
SHOX2
|
short stature homeobox 2
|
|
SIGMAR1
|
sigma non-opioid intracellular receptor 1
|
|
SIRT1
|
sirtuin 1
|
|
SIRT6
|
sirtuin 6
|
|
SIX6
|
SIX homeobox 6
|
|
SKP2
|
S-phase kinase-associated protein 2, E3 ubiquitin protein ligase
|
|
SLC19A1
|
solute carrier family 19 (folate transporter), member 1
|
|
SLC29A1
|
solute carrier family 29 (equilibrative nucleoside transporter), member 1
|
|
SLC2A1
|
solute carrier family 2 (facilitated glucose transporter), member 1
|
|
SLC30A8
|
solute carrier family 30 (zinc transporter), member 8
|
|
SLC39A3
|
solute carrier family 39 (zinc transporter), member 3
|
|
SLC5A5
|
solute carrier family 5 (sodium/iodide cotransporter), member 5
|
|
SLC6A3
|
solute carrier family 6 (neurotransmitter transporter), member 3
|
|
SLC6A4
|
solute carrier family 6 (neurotransmitter transporter), member 4
|
|
SLC6A5
|
solute carrier family 6 (neurotransmitter transporter), member 5
|
|
SLC6A8
|
solute carrier family 6 (neurotransmitter transporter), member 8
|
|
SLC7A5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5
|
|
SLC9A3
|
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3
|
|
SLCO1C1
|
solute carrier organic anion transporter family, member 1C1
|
|
SLCO2A1
|
solute carrier organic anion transporter family, member 2A1
|
|
SMAD2
|
SMAD family member 2
|
|
SMAD3
|
SMAD family member 3
|
|
SMAD4
|
SMAD family member 4
|
|
SMAD7
|
SMAD family member 7
|
|
SMARCD3
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3
|
|
SMYD2
|
SET and MYND domain containing 2
|
|
SNAI1
|
snail family zinc finger 1
|
|
SNAP25
|
synaptosomal-associated protein, 25kDa
|
|
SNCA
|
synuclein, alpha (non A4 component of amyloid precursor)
|
|
SNX27
|
sorting nexin family member 27
|
|
SOD1
|
superoxide dismutase 1, soluble
|
|
SOD2
|
superoxide dismutase 2, mitochondrial
|
|
SOST
|
sclerostin
|
|
SOX2
|
SRY (sex determining region Y)-box 2
|
|
SP1
|
Sp1 transcription factor
|
|
SP110
|
SP110 nuclear body protein
|
|
SPAG11B
|
sperm associated antigen 11B
|
|
SPAG16
|
sperm associated antigen 16
|
|
SPARC
|
secreted protein, acidic, cysteine-rich (osteonectin)
|
|
SPHK1
|
sphingosine kinase 1
|
|
SPI1
|
Spi-1 proto-oncogene
|
|
SPINK1
|
serine peptidase inhibitor, Kazal type 1
|
|
SPP1
|
secreted phosphoprotein 1
|
|
SRC
|
SRC proto-oncogene, non-receptor tyrosine kinase
|
|
SREBF2
|
sterol regulatory element binding transcription factor 2
|
|
SSTR1
|
somatostatin receptor 1
|
|
STAT1
|
signal transducer and activator of transcription 1, 91kDa
|
|
STAT3
|
signal transducer and activator of transcription 3 (acute-phase response factor)
|
|
STAT4
|
signal transducer and activator of transcription 4
|
|
STAT5A
|
signal transducer and activator of transcription 5A
|
|
STAT6
|
signal transducer and activator of transcription 6, interleukin-4 induced
|
|
STMN1
|
stathmin 1
|
|
SUN1
|
Sad1 and UNC84 domain containing 1
|
|
T
|
T, brachyury homolog (mouse)
|
|
TARDBP
|
TAR DNA binding protein
|
|
TAS2R38
|
taste receptor, type 2, member 38
|
|
TBP
|
TATA box binding protein
|
|
TBXAS1
|
thromboxane A synthase 1 (platelet)
|
|
TCF7L2
|
transcription factor 7-like 2 (T-cell specific, HMG-box)
|
|
TERT
|
telomerase reverse transcriptase
|
|
TEX101
|
testis expressed 101
|
|
TF
|
transferrin
|
|
TFAP2B
|
transcription factor AP-2 beta (activating enhancer binding protein 2 beta)
|
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)
|
|
TFR2
|
transferrin receptor 2
|
|
TGFB1
|
transforming growth factor, beta 1
|
|
TGFB3
|
transforming growth factor, beta 3
|
|
TGFBI
|
transforming growth factor, beta-induced, 68kDa
|
|
THAP1
|
THAP domain containing, apoptosis associated protein 1
|
|
THBD
|
thrombomodulin
|
|
THBS1
|
thrombospondin 1
|
|
THPO
|
thrombopoietin
|
|
THRB
|
thyroid hormone receptor, beta
|
|
TIMP1
|
TIMP metallopeptidase inhibitor 1
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
TIMP3
|
TIMP metallopeptidase inhibitor 3
|
|
TIRAP
|
toll-interleukin 1 receptor (TIR) domain containing adaptor protein
|
|
TJP1
|
tight junction protein 1
|
|
TLR2
|
toll-like receptor 2
|
|
TLR4
|
toll-like receptor 4
|
|
TLR7
|
toll-like receptor 7
|
|
TLR8
|
toll-like receptor 8
|
|
TLR9
|
toll-like receptor 9
|
|
TMPO
|
thymopoietin
|
|
TMTC1
|
transmembrane and tetratricopeptide repeat containing 1
|
|
TMTC2
|
transmembrane and tetratricopeptide repeat containing 2
|
|
TNC
|
tenascin C
|
|
TNF
|
tumor necrosis factor
|
|
TNFRSF10B
|
tumor necrosis factor receptor superfamily, member 10b
|
|
TNFRSF11B
|
tumor necrosis factor receptor superfamily, member 11b
|
|
TNFRSF8
|
tumor necrosis factor receptor superfamily, member 8
|
|
TNFSF10
|
tumor necrosis factor (ligand) superfamily, member 10
|
|
TNFSF11
|
tumor necrosis factor (ligand) superfamily, member 11
|
|
TNFSF4
|
tumor necrosis factor (ligand) superfamily, member 4
|
|
TNFSF9
|
tumor necrosis factor (ligand) superfamily, member 9
|
|
TNKS
|
tankyrase, TRF1-interacting ankyrin-related ADP-ribose polymerase
|
|
TNNI3
|
troponin I type 3 (cardiac)
|
|
TNNT2
|
troponin T type 2 (cardiac)
|
|
TOP1
|
topoisomerase (DNA) I
|
|
TP53
|
tumor protein p53
|
|
TP53AIP1
|
tumor protein p53 regulated apoptosis inducing protein 1
|
|
TP63
|
tumor protein p63
|
|
TP73
|
tumor protein p73
|
|
TPM2
|
tropomyosin 2 (beta)
|
|
TPM3
|
tropomyosin 3
|
|
TPMT
|
thiopurine S-methyltransferase
|
|
TRIM2
|
tripartite motif containing 2
|
|
TRIM22
|
tripartite motif containing 22
|
|
TRPA1
|
transient receptor potential cation channel, subfamily A, member 1
|
|
TRPM8
|
transient receptor potential cation channel, subfamily M, member 8
|
|
TSHR
|
thyroid stimulating hormone receptor
|
|
TSLP
|
thymic stromal lymphopoietin
|
|
TSPY1
|
testis specific protein, Y-linked 1
|
|
TWIST1
|
twist family bHLH transcription factor 1
|
|
TXNIP
|
thioredoxin interacting protein
|
|
TXNRD2
|
thioredoxin reductase 2
|
|
TYMP
|
thymidine phosphorylase
|
|
TYMS
|
thymidylate synthetase
|
|
UBE2C
|
ubiquitin-conjugating enzyme E2C
|
|
UBP1
|
upstream binding protein 1 (LBP-1a)
|
|
UCP2
|
uncoupling protein 2 (mitochondrial, proton carrier)
|
|
UGT1A
|
UDP glucuronosyltransferase 1 family, polypeptide A complex locus
|
|
UGT1A1
|
UDP glucuronosyltransferase 1 family, polypeptide A1
|
|
UGT1A6
|
UDP glucuronosyltransferase 1 family, polypeptide A6
|
|
UPF1
|
UPF1 regulator of nonsense transcripts homolog (yeast)
|
|
UPK2
|
uroplakin 2
|
|
VASP
|
vasodilator-stimulated phosphoprotein
|
|
VCAM1
|
vascular cell adhesion molecule 1
|
|
VCAN
|
versican
|
|
VCP
|
valosin containing protein
|
|
VDR
|
vitamin D (1,25- dihydroxyvitamin D3) receptor
|
|
VEGFA
|
vascular endothelial growth factor A
|
|
VEGFC
|
vascular endothelial growth factor C
|
|
VIM
|
vimentin
|
|
VIP
|
vasoactive intestinal peptide
|
|
VKORC1
|
vitamin K epoxide reductase complex, subunit 1
|
|
VNN1
|
vanin 1
|
|
VWF
|
von Willebrand factor
|
|
WEE1
|
WEE1 G2 checkpoint kinase
|
|
WFDC2
|
WAP four-disulfide core domain 2
|
|
WFS1
|
Wolfram syndrome 1 (wolframin)
|
|
WSB1
|
WD repeat and SOCS box containing 1
|
|
WT1
|
Wilms tumor 1
|
|
XAF1
|
XIAP associated factor 1
|
|
XDH
|
xanthine dehydrogenase
|
|
XIAP
|
X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
|
|
XPC
|
xeroderma pigmentosum, complementation group C
|
|
XPO1
|
exportin 1
|
|
XRCC1
|
X-ray repair complementing defective repair in Chinese hamster cells 1
|
|
XRCC3
|
X-ray repair complementing defective repair in Chinese hamster cells 3
|
|
XRCC4
|
X-ray repair complementing defective repair in Chinese hamster cells 4
|
|
YAP1
|
Yes-associated protein 1
|
|
YBX1
|
Y box binding protein 1
|
|
YWHAH
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta
|
|
YWHAZ
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta
|
|
YY1
|
YY1 transcription factor
|
|
ZPBP2
|
zona pellucida binding protein 2
|
